| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -19.68M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, INO returned -39.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -32.2% |
| 1 year | -39.8% |
| 5 years | -98.9% |
| 10 years | -98.9% |
| All-time high | $1,416.00 (Feb 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in INO would be worth today ›No. Inovio Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Inovio Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol INO.
Inovio Pharmaceuticals, Inc. is part of the Healthcare sector.
Inovio Pharmaceuticals, Inc. has a market cap of 122.01M USD, based on the latest quote.
Inovio Pharmaceuticals, Inc. is expected to report earnings around Nov 10, 2026. That date is an estimate and has not been confirmed by the company.
